NCT02080260 - A Study of Regorafenib in Advanced Pancreatic Cancer Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 6, 2014

Primary Completion Date

June 28, 2017

Study Completion Date

June 28, 2017

Conditions

Pancreatic Cancer

Interventions

DRUG

regorafenib

Single agent drug therapy with regorafenib

Trial Locations (12)

Levine Cancer Institute-Albemarle, Albemarle

Levine Cancer Institute - Concord, Concord

Levine Cancer Institute-Monroe, Monroe

Levine Cancer Institute - Cleveland, Shelby

Levine Cancer Institute-South Tryon, Charlotte

Levine Cancer Institute, Charlotte

Levine Cancer Institute - Pineville, Charlotte

Levine Cancer Institute - Southpark, Charlotte

Levine Cancer Institute - Mallard Creek, Charlotte

Levine Cancer Institute - University, Charlotte

Levine Cancer Institute - Ballantyne, Charlotte

Low Country Hematology Oncology, Charleston